loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Thymosin Beta-4

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Thymosin Beta 4

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Thymosin Beta 4 Research Leads Toward Potential Future Anti-aging Therapy
    Thymosin Beta 4 Research Leads Toward Potential Future Anti-aging Therapy

    31 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/thymosin-beta-4-research-leads-toward-potential-future-anti-aging-therapy-301734403.html

    PR NEWSWIRE
    31 Jan 2023
    Share Share
    New Research Demonstrates Thymosin Beta 4's Potential Positive Effects
    New Research Demonstrates Thymosin Beta 4's Potential Positive Effects

    05 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/new-research-demonstrates-thymosin-beta-4s-potential-positive--effects-on-alzheimers-disease-301392841.html

    PRNEWSWIRE
    05 Oct 2021
    Share Share
    Tailor Made Compounding (Sterile Drug Manufacturer) Receives FDA Form 483
    Tailor Made Compounding (Sterile Drug Manufacturer) Receives FDA Form 483

    30 Oct 2018

    // FDA

    https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm627650.pdf

    FDA
    30 Oct 2018
    Share Share